Please login to the form below

Not currently logged in

NHS reforms mean pharma needs more holistic, localised approach

Survey emphasises need to address wider needs of stakeholders in local economies following implementation of Health Bill

A holistic approach driven by patient outcomes is a key priority for England's newly set up clinical commissioning groups (CCGs), according to a new survey.

The CCGs, set up to replace primary care trusts and strategic health authorities, also emphasised long-term value focused on population needs of local economies and social functioning as key aims within their new remit to provide commissioning services in the country.

The findings will have repercussions for the pharma industry, according to Equip Communications, which carried out the survey, as companies will need to take a different and broader approach to marketing treatments, addressing a much wider range of needs with stakeholder groups who are “more interdependent than ever before”.

Equp white paper - Creating meaningful brand value propositions, delivered locallySuch a strategy means pharma companies will need to look beyond clinical trials, and instead learn how to develop a marketing approach that takes into account healthcare economies on a local level.

For further details on what NHS reforms mean for commissioning, read Creating meaningful brand value propositions, delivered locally published by Equip Communications.

30th July 2012


Featured jobs

Subscribe to our email news alerts


Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...